Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 561580 of 20,252 grants

Active NON-SBIR/STTR RPGS
Biostatistics and Computational Biology (BCB) Core
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2024 – 2029

CORE 2: BIOSTATISTICS AND COMPUTATIONAL BIOLOGY: SUMMARY/ABSTRACT The Biostatistics and Computational Biology (BCB) Core for this P01 will enable cost-effective data processing, an...

Active NON-SBIR/STTR RPGS
Core 3: MPIP.
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2024 – 2029

CORE 3_MULTIPARAMETER IMAGING AND PATHOLOGY: SUMMARY/ABSTRACT One basic function of Core 3 includes the collection and distribution of specimens and patient samples to P01 investig...

Active NON-SBIR/STTR RPGS
3D In vivo dosimetry for FLASH proton therapy
NATIONAL CANCER INSTITUTE University of California-Irvine United States 2024 – 2029

ABSTRACT: This U01 application aims to (1) develop a robust protoacoustic dosimeter for 3D in vivo dosimetry in proton FLASH therapy, which is essential for its clinical applicatio...

$6.41M
USD
Active NON-SBIR/STTR RPGS
Identifying and overcoming mechanisms of resistance to effectively target the TBL1/β-catenin signaling axis for high-risk osteosarcoma
NATIONAL CANCER INSTITUTE Emory University United States 2024 – 2029

Osteosarcoma (OS) is the most common bone malignancy in the pediatric population. Overall survival rates remain about 65-75% and are significantly worse for patients with metastati...

$3.77M
USD
Active NON-SBIR/STTR RPGS
Addressing tumor heterogeneity in pediatric gliomas with precision adoptive T cell therapy
NATIONAL CANCER INSTITUTE University of Florida United States 2024 – 2029

Project Summary Tumor-specific immunotherapy is a promising modality capable of improving clinical outcomes for children affected with high-grade glioma (HGG). We have pioneered a...

$4.75M
USD
Active NON-SBIR/STTR RPGS
Developing liquid biopsy tests for malignant effusions using artificial intelligence-assisted, morphology-based isolation of tumor cells
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT Background. Malignant effusions (ME) are frequent complications of metastatic breast cancer (MBC) associated with severe symptoms and dire prognosis. Treat...

$6.79M
USD
Active NON-SBIR/STTR RPGS
Integrative Analysis and Visualization Platform for Cancer Regulatory Genomics
NATIONAL CANCER INSTITUTE University of Massachusetts Med Sch Worc... United States 2024 – 2027

PROJECT SUMMARY Recent advancements in next-generation sequencing technologies have resulted in the generation of vast quantities of publicly accessible data that are specific to c...

$4.17M
USD
Active NON-SBIR/STTR RPGS
Modulating growth, progression and metastasis in breast cancer by inhibiting MDA-9
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2024 – 2029

Despite therapeutic advances, the 5-year survival rate from metastatic triple negative breast cancer (TNBC) has not improved significantly for 30-years. As such, significant benefi...

$6.22M
USD
Active NON-SBIR/STTR RPGS
Implementing Sustainable mobile health Technology to Optimize smoking cessation Program for Lao people with HIV (I-STOP)
NATIONAL CANCER INSTITUTE University of Oklahoma Hlth Sciences Ctr United States 2024 – 2029

PROJECT SUMMARY: Tobacco use remains the leading modifiable risk factor for preventing cancer globally, particularly among people with HIV (PWH). In Lao People's Democratic Re...

$6.54M
USD
Active NON-SBIR/STTR RPGS
Advancing novel therapeutics and translational science to close the survivorship gap in pediatric, adolescent and young adult (AYA) lymphoma
NATIONAL CANCER INSTITUTE Emory University United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT: Hodgkin Lymphoma (HL) has its first incidence peak in the adolescent and young adults (AYA) years. Despite the success of chemotherapy and radiation in yo...

$1.79M
USD
Active NON-SBIR/STTR RPGS
Washington University ACCERT center
NATIONAL CANCER INSTITUTE Washington University United States 2024 – 2029

Project Summary (Abstract) Goal: The overall goal of the WashU ACCERT is to advance cancer control equity through community - engaged multilevel research interventions that address...

$18.88M
USD
Active NON-SBIR/STTR RPGS
Administrative Core
NATIONAL CANCER INSTITUTE Washington University United States 2024 – 2029

PROJECT SUMMARY – ADMINISTRATIVE CORE The Administrative Core will provide the structure for effective and efficient operation and maintenance of the Washington University Advancin...

Active NON-SBIR/STTR RPGS
Research Measures, Methods and Data Management Core
NATIONAL CANCER INSTITUTE Washington University United States 2024 – 2029

Project Summary- Research Methods, Measures, and Data Management Core The Research Methods, Measures, and Data Management (RMMDM) Core will advance the goal of the WashU-ACCERT cen...

Active NON-SBIR/STTR RPGS
Social Determinants of Health Research Project
NATIONAL CANCER INSTITUTE Washington University United States 2024 – 2029

Project Summary- Social Determinants of Health Multilevel Intervention Financial toxicity –hardships caused by the costs of cancer treatment– are common and have substantial impact...

Active NON-SBIR/STTR RPGS
Community Responsive Research Program
NATIONAL CANCER INSTITUTE Washington University United States 2024 – 2029

The overall goal of WashU-ACCERT is to advance cancer control equity through community-engaged multi- level research that addresses the impact of social determinants of health on c...

Active NON-SBIR/STTR RPGS
Active HCV diagnosis to support prevention of HCC in LMICs
NATIONAL CANCER INSTITUTE Northwestern University United States 2024 – 2029

Project Summary HCV is a major threat worldwide, infecting over 58 million people and causing 300,000 deaths from HCV-related cirrhosis or hepatocellular carcinoma (HCC) each year....

$5.92M
USD
Active NON-SBIR/STTR RPGS
Regulation of Androgen Receptor by NXTAR Long non-coding RNA in Prostate Cancer and its Therapeutic Implications
NATIONAL CANCER INSTITUTE Washington University United States 2024 – 2029

Abstract Androgen receptor (AR) signaling continues to play a dominant role in all stages of prostate cancer (PC), including castration-resistant prostate cancers (CRPCs) that have...

$5.49M
USD
Active NON-SBIR/STTR RPGS
Role of LAM-specific TREM1 in leukemogenesis
NATIONAL CANCER INSTITUTE University of Pittsburgh At Pittsburgh United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT Cancer progression is heavily influenced by supportive cells in the tumor microenvironment. Macrophages, an important component of tissue microenvironment,...

$5.18M
USD
Active NON-SBIR/STTR RPGS
The Personalized Remote Radiation Tracking Portable Organ Dosimetry Devise (PRRT PODD)
NATIONAL CANCER INSTITUTE University of Washington United States 2024 – 2029

Theranostics is a type of precision medicine in which targeted radiolabeled compounds are being used for both diagnosis and treatment. Targeted therapies can increase therapeutic e...

$5.96M
USD
Active NON-SBIR/STTR RPGS
ExpLoiting thErapeutic VulnerAbilities in hepaTocEllular carcinoma (ELEVATE)
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2024 – 2029

OVERALL: SUMMARY Hepatocellular carcinoma (HCC), the primary malignancy of hepatocytes, is a diagnosis with bleak outcomes. With the alarming rise in global obesity incidence, obes...

$26.78M
USD